Evidence map›Paper›PMID 34077722›Full record

ArticleCell reports2021

Reliance on Cox10 and oxidative metabolism for antigen-specific NK cell expansion.

Annelise Y Mah-Som, Molly P Keppel, Joshua M Tobin, Ana Kolicheski, Nermina Saucier, Veronika Sexl, Anthony R French, Julia A Wagner, Todd A Fehniger, Megan A Cooper

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. The role of mTORC2/RICTOR in immune cells and inflammatory diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Fatty acid oxidation fuels natural killer cell responses against infection and cancer.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Annelise Y Mah-SomDepartment of Pediatrics, Division of Rheumatology/Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Molly P KeppelDepartment of Pediatrics, Division of Rheumatology/Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Joshua M TobinDepartment of Pediatrics, Division of Rheumatology/Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; Medical Scientist Training Program, Washington University School of Medicine, St. Louis, MO 63110, USA.
Ana KolicheskiDepartment of Pediatrics, Division of Rheumatology/Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Nermina SaucierDepartment of Pediatrics, Division of Rheumatology/Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Veronika SexlDepartment of Biomedical Science, University of Veterinary Medicine of Vienna, Vienna, Austria.
Anthony R FrenchDepartment of Pediatrics, Division of Rheumatology/Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Julia A WagnerMedical Scientist Training Program, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Todd A FehnigerDepartment of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Megan A CooperDepartment of Pediatrics, Division of Rheumatology/Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: cooper_m@wustl.edu.
Washington University in St. Louis · USUniversity of Veterinary Medicine Vienna · AT

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic LeukemiaP50CA171963 · NCI · WASHINGTON UNIVERSITY · PI TODD A FEHNIGER · 2013 to 2026
$31.6M
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTIONR01AI078994 · NIAID · WASHINGTON UNIVERSITY · PI FRENCH, ANTHONY R · 2009 to 2019
$3.8M
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPYR01CA205239 · NCI · WASHINGTON UNIVERSITY · PI FEHNIGER, TODD A · 2017 to 2020
$2.4M
METABOLIC REGULATION OF NATURAL KILLER CELL ACTIVATIONR01AI127752 · NIAID · WASHINGTON UNIVERSITY · PI COOPER, MEGAN ANNE · 2017 to 2021
$1.9M
Metabolic Regulation of Natural Killer Cell ActivationR56AI127752 · NIAID · WASHINGTON UNIVERSITY · PI COOPER, MEGAN ANNE · 2023 to 2023
$300k
Metabolic requirements of NK cell responses to viral infectionF30AI129110 · NIAID · WASHINGTON UNIVERSITY · PI MAH-SOM, ANNELISE YOO · 2017 to 2019
$103k
Austrian Science Fund FWF P 28571NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NCI NIH HHS P30 CA091842NCI NIH HHS P50 CA171963NCI NIH HHS R01 CA205239NIAID NIH HHS F30 AI129110NIAID NIH HHS R01 AI078994NIAID NIH HHS R01 AI127752NIAID NIH HHS R56 AI127752NIGMS NIH HHS T32 GM007200
6 · The paper itself

Abstract

Natural killer (NK) cell effector functions are dependent on metabolic regulation of cellular function; however, less is known about in vivo metabolic pathways required for NK cell antiviral function. Mice with an inducible NK-specific deletion of Cox10, which encodes a component of electron transport chain complex IV, were generated to investigate the role of oxidative phosphorylation in NK cells during murine cytomegalovirus (MCMV) infection. Ncr1-Cox10

Indexed as

Adenylate KinaseAlkyl and Aryl TransferasesAnimalsAntigensCell ProliferationCytomegalovirus InfectionsEnzyme ActivationGene DeletionImmunologic MemoryKiller Cells, NaturalLigandsMembrane ProteinsMiceMice, Inbred C57BLMuromegalovirusOxidation-ReductionAdenylate KinaseAlkyl and Aryl TransferasesAntigensCOX10 protein, mouseLigandsMembrane ProteinsTOR Serine-Threonine KinasesCox10metabolismmurine cytomegalovirusNK cellsoxidative phosphorylationproliferation

Identifiers

PMID34077722
PMCPMC8229496
OpenAlexW3164692932

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.